We carried out a seroepidemiological study on 63 patients undergoing organ transplantation in order to determine viral markers like CMV, HTLV III, HS and V/Z. The antibodies valuation was carried out by enzyme-linked immunosorbent assays (ELISA-Abbott) and complement fixation test. All the tested markers give a high percentage of positivity even if the values relevant to anti-HTLV III antibodies can not be related to infection but, probably, to anti-HLA-Dr antibodies.
[Seroepidemiologic studies in 63 patients given organ transplants in relation to cytomegalovirus, herpes simplex, varicella-zoster and HTLV-III: validity and limits] / D., Lilli; G., Lorino; P., Cipriani; Berloco, Pasquale Bartolomeo; Pretagostini, Renzo; C., Mancini. - In: BOLLETTINO DELL'ISTITUTO SIEROTERAPICO MILANESE. - ISSN 0021-2547. - STAMPA. - 66:3(1987), pp. 198-201.
[Seroepidemiologic studies in 63 patients given organ transplants in relation to cytomegalovirus, herpes simplex, varicella-zoster and HTLV-III: validity and limits].
BERLOCO, Pasquale Bartolomeo;PRETAGOSTINI, Renzo;
1987
Abstract
We carried out a seroepidemiological study on 63 patients undergoing organ transplantation in order to determine viral markers like CMV, HTLV III, HS and V/Z. The antibodies valuation was carried out by enzyme-linked immunosorbent assays (ELISA-Abbott) and complement fixation test. All the tested markers give a high percentage of positivity even if the values relevant to anti-HTLV III antibodies can not be related to infection but, probably, to anti-HLA-Dr antibodies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
